Resources
About Us
Medical Ceramics Market Size, Share, Forecast, & Trends Analysis by Type (Bioinert [Alumina, Zirconia, Carbon], Biocompatible [Hydroxyapatite, Glass Ceramics, Calcium Carbonate], Piezoelectric), Application (Dental, Orthopedic) - Global Forecast to 2030
Report ID: MRHC - 104855 Pages: 450 Jun-2024 Formats*: PDF Category: Healthcare Delivery: 24 to 72 Hours Download Free Sample ReportThe Medical Ceramics Market is expected to reach $29.93 billion by 2030, at a CAGR of 6.2% from 2024 to 2030. The growth of this market can be primarily attributed to the growing utilization of active implantable devices, the rising adoption of ceramics in drug delivery, the high acceptance of ceramics in dental and orthopedic implants, the rising demand for bio-ceramics in cosmetic dentistry, and the increasing demand for custom engineered medical implants. Moreover, emerging economies and technological advancements in ceramics, such as high heat-compatible ceramics, chemical-resistant ceramics, complex geometric medical ceramics, and technical ceramics, are expected to offer growth opportunities for the players operating in this market.
Ceramics or bio-ceramics have gained acceptance in the dental and orthopedic fields due to their excellent mechanical properties, biocompatibility, and aesthetic appeal. In dental practices, ceramics or bio-ceramics are widely used in restorative dentistry and have emerged as an attractive alternative to traditional materials like metal or composite resin. Ceramics are commonly used in dental implants, veneers, crowns, and bridges.
In orthopedics, ceramics are used for various applications due to their excellent biocompatibility, strength, wear resistance, and low-friction properties. Ceramic materials like alumina and zirconia are used in total hip, knee, and shoulder replacements. Ceramic implants provide better wear resistance than traditional metal or polyethylene components, offering increased implant lifespan.
Porous ceramics, such as hydroxyapatite and tricalcium phosphate, are used as bone graft substitutes. These materials promote bone growth and gradually resorb, allowing new bone formation. Ceramic implants are used in spinal fusion surgeries to promote bone growth and stabilize the spine.
Click here to: Get a Free Sample Copy of this report
Ceramic-based drug carriers have gained much attention with advancements in medicine, pharmaceutics, and material science. Popular bio-ceramics include beta-tricalcium phosphate (β-TCP), hydroxyapatite, mesoporous silica, and zirconia hydroxyapatite composite. Bio-ceramics are important parts of some inorganic-organic composites used as drug carriers.
The advantages of ceramic-based drug carriers include low toxicity and adjustable sizes and structures that are favorable for loading nano-sized drugs. Ceramics have good biocompatibility, biodegradability, and biological stability. Some ceramics are environmentally sensitive and can respond to light, magnetism, or heat. These characteristics make them feasible for accurate targeted drug delivery.
Additionally, increasing funding and research grants to develop ceramic-based drug delivery systems are expected to further drive the adoption of ceramics in the pharmaceutical industry. For instance, in 2024, Aldena Therapeutics Inc. (U.K.), a developer of siRNA-based therapies for dermatological indications, and Empa, the Swiss Federal research institute for material science and technology, received a grant of $656,221.2 (CHF 600,000) from Innosuisse, the Swiss Innovation Agency. This grant was aimed at co-developing microneedle particles as a new skin delivery system. This microneedle-particle technology, called STAR particles, are star-shaped ceramic microparticles that enable the delivery of large, water-soluble molecules into the skin at the site of application.
The Use of Medical Ceramics in Chemotherapy is the Prevailing Market Trend
The use of medical ceramics in cancer diagnostics and treatment has shown positive results and is a growing area of interest. Currently, cancer is treated through surgical procedures wherein the tumor is removed, followed by radiotherapy and/or chemotherapy to ensure that the remaining microscopic bits of cancer are destroyed. However, the side effects of chemotherapy can damage healthy cells, cause infections, and weaken the immune system.
The use of medical ceramics in cancer diagnosis and therapy has proved to be useful, and the phosphate family is being increasingly explored by researchers. Furthermore, hybrid and composite nanoparticles have great potential in the detection and treatment of cancer. Mesoporous silica nanoparticle-based theranostics (therapy + diagnostics) is among the most researched systems due to its potential as a carrier for imaging therapeutic agents or contrast agents. Hence, the growing use of medical ceramics in cancer treatment is expected to accelerate market growth in the coming years.
Bio-ceramic materials, such as alumina and zirconia, are majorly used in the fabrication of dental implants. These materials offer excellent corrosion resistance, biocompatibility, and mechanical properties, making them suitable options for replacing missing teeth. Bio-ceramic implants offer better integration with the jawbone compared to other materials, providing a stable foundation for dental prosthetics.
Calcium silicate-based bio-ceramics are majorly used in root canal therapy. These bio-ceramic root repair materials and sealers exhibit high biocompatibility, superior sealing ability, and antibacterial properties, which results in the success of endodontic procedures. Bio-ceramics help in sealing and filling the root canal space, preventing subsequent reinfection and microbial ingress. Further, these materials promote the regeneration of periapical tissues, contributing to the long-term benefits of root canal treatments.
Advanced ceramic components are incorporated into various drug delivery devices due to ceramics’ natural chemical inertness and resistance to acidic solutions. Ceramic-to-metal seals are incorporated into medical devices and instruments, including pacemakers and artificial joint assemblies. Ceramics can be used to make incredibly complex and small geometric shapes, still maintaining their high chemical and heat resistance. As a result, ceramic technology has become an integral part of the medical industry.
The chemical processing industry requires materials that are resistant to the effects of strong alkalis and acids for applications such as pump, valve, and seal components. For instance, SSN Nilcra SSE Grade is a high-strength ceramic, which is a hard-wearing, reliable, hard grade, and nonporous silicon nitride designed by Morgan Advanced Materials plc (U.K.) for applications including custom-engineered medical implants. This ceramic has high durability, toughness, corrosion, and wear resistance (up to 1,000°C [1,832°F]). The development of such products and the increasing penetration of chemical-resistant and medical ceramics are generating significant market growth opportunities.
Based on type, the medical ceramics market is segmented into bioinert, biocompatible, and piezoelectric ceramics. In 2024, the bioinert ceramics segment is expected to account for the largest share of 56% of the medical ceramics market. Alumina and zirconia are the most widely used ceramics in orthopedic and dental implants and restorations. These ceramics are inert in nature, meaning that they do not react with tissues in the body. The growing number of dental restorations and the rising adoption of orthopedic implants are key factors contributing to the large market share of the bioinert ceramics segment. Furthermore, the increasing prevalence of arthritis is also expected to drive the segment’s growth.
However, the biocompatible ceramics segment is projected to record the highest growth rate of 6.9% during the forecast period 2024–2030. The growth of this segment is driven by the increasing demand for high-quality biocompatible medical ceramics and the high intrinsic strength of ceramics.
Based on application, the medical ceramics market is segmented into orthopedic, dental, cosmetic/plastic surgery, surgical instruments, and other applications.
In 2024, the orthopedic segment is expected to account for the largest share of the medical ceramics market. The large market share of this segment can be attributed to the high adoption of ceramics in orthopedic implants, the growing use of bio-ceramics in skeletal injuries, and the increasing prevalence of musculoskeletal disorders like osteoarthritis and rheumatoid arthritis.
However, the dental segment is projected to register the highest growth rate of 6.3% during the forecast period 2024–2030. The growth of this segment is driven by the increasing demand for clear and invisible dental prostheses, advancements in mechanical properties and fabrication methods of dental ceramic materials, and the high compressive strength of ceramics in dental applications.
In 2024, North America is expected to account for the largest share of 32.9% of the medical ceramics market, followed by Europe and Asia-Pacific. In North America, the U.S. is expected to account for the major market share in 2024, mainly due to the development of advanced ceramics for use in dental and orthopedic procedures, high healthcare expenditures, increasing awareness, and the rising demand for custom-engineered medical implants.
Moreover, Asia-Pacific is slated to register the highest growth rate during the forecast period 2024–2030 due to growing economies such as India (CAGR 8.1%) and China (CAGR 7.3%). The growth of the medical ceramics market in APAC is also driven by the increasing adoption of medical ceramics for dental procedures owing to an increasing number of people needing restorative dentistry, the growth in cosmetic dentistry in countries such as India and China and rising medical tourism for orthopedic procedures in the region.
The report offers a competitive analysis based on an extensive assessment of the leading players’ product portfolios, geographic presence, financials, and key growth strategies adopted in the last 3–4 years. Some of the key players operating in the medical ceramics market are 3M Company (U.S.), De Puy Synthes (U.S.), CoorsTek, Inc. (U.S.), CeramTec GmbH (Germany), KYOCERA Corporation (U.S.), Institut Straumann AG (Switzerland), Morgan Advanced Materials (U.K.), APC International, Ltd. (U.S.), Materion Corporation (U.S.), and Elan Technology (U.S.).
In March 2024, Lithoz GmbH (Austria) announced the launch of 3D-printed ceramic serial production at Ceramitec 2024.
In December 2024, Kuraray Noritake Dental Inc. (Japan) expanded the production capacity for ceramic dental materials at its Miyoshi Plant (Miyoshi City, Aichi Prefecture) to accelerate the expansion of its dental materials business.
Particulars |
Details |
Number of Pages |
~450 |
Format |
|
Forecast Period |
2024–2030 |
Base Year |
2022 |
CAGR (Value) |
6.2% |
Market Size (Value) |
USD 29.93 Billion by 2030 |
Segments Covered |
By Type
By Application
|
Countries Covered |
North America (U.S., Canada), Europe (France, Germany, U.K., Italy, Spain, Switzerland, Austria, and Rest of Europe), Asia-Pacific (China, India, Japan, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa |
Key Companies Profiled |
3M Company (U.S.), De Puy Synthes (U.S.), CoorsTek, Inc. (U.S.), CeramTec GmbH (Germany), KYOCERA Corporation (U.S.), Institut Straumann AG (Switzerland), Morgan Advanced Materials (U.K.), APC International, Ltd. (U.S.), Materion Corporation (U.S.), and Elan Technology (U.S.) |
This study offers a detailed assessment of the medical ceramics market, including the market sizes & forecasts for market segments by type and application. The study also provides an in-depth analysis of various segments & subsegments of the medical ceramics market at the regional and country levels.
The medical ceramics market is projected to reach $29.93 billion by 2030, at a CAGR of 6.2% during the forecast period.
In 2024, the bioinert ceramics segment is expected to account for the largest market share. The growing adoption of dental and orthopedic implants is the key factor supporting the large market share of this segment. Further, the increasing prevalence of arthritis is expected to drive the segment’s growth during the forecast period.
In 2024, the orthopedic segment is expected to account for the largest market share, mainly due to the high adoption of ceramics in orthopedic implants, the growing use of bio-ceramics in skeletal injuries, and the increasing prevalence of musculoskeletal disorders like osteoarthritis and rheumatoid arthritis.
The growth of the medical ceramics market is driven by the growing utilization of active implantable devices, the rising adoption of ceramics in drug delivery, the high acceptance of ceramics in dental and orthopedic implants, the rising demand for bio-ceramics in cosmetic dentistry, and the increasing demand for custom-engineered medical implants.
The key players profiled in the medical ceramics market study are 3M Company (U.S.), De Puy Synthes (U.S.), CoorsTek, Inc. (U.S.), CeramTec GmbH (Germany), KYOCERA Corporation (U.S.), Institut Straumann AG (Switzerland), Morgan Advanced Materials (U.K.), APC International, Ltd. (U.S.), Materion Corporation (U.S.), and Elan Technology (U.S.).
Countries such as India and China are expected to offer significant growth opportunities for the vendors in this market due to factors such as the increasing adoption of medical ceramics for dental procedures, the growth in cosmetic dentistry in these countries, and rising medical tourism for orthopedic, dental, and other surgical procedures.
Published Date: Oct-2024
Published Date: Aug-2024
Published Date: Jun-2024
Published Date: Jun-2024
Published Date: Jun-2024
Please enter your corporate email id here to view sample report.
Subscribe to get the latest industry updates